Report copyright - Cetuximab plus weekly oxaliplatin/5FU/FA (FUFOX) in 1 st line metastatic gastric cancer. Final results from a multicenter phase II study of the AIO upper
Please pass captcha verification before submit form
Please pass captcha verification before submit form